Literature DB >> 27714693

Microglia in Cancer: For Good or for Bad?

Anna Carolina Carvalho da Fonseca1, Rackele Amaral1, Celina Garcia1, Luiz Henrique Geraldo1, Diana Matias1, Flavia Regina Souza Lima2.   

Abstract

Glioblastoma is a malignant tumor of astrocytic origin that is highly invasive, proliferative and angiogenic. Despite current advances in multimodal therapies, such as surgery, radio- and chemotherapy, the outcome for patients with glioblastoma is nearly always fatal. The glioblastoma microenvironment has a tremendous influence over the tumor growth and spread. Microglia and macrophages are abundant cells in the tumor mass. Increasing evidence indicates that glioblastoma recruits these cell populations and signals in a way that microglia and macrophages are subverted to promote tumor progression. In this chapter, we discuss some aspects of the interaction between microglia and glioblastoma, consequences of this interaction for tumor progression and the possibility of microglial cells being used as therapeutic vectors, which opens up new alternatives for the development of GBM therapies targeting microglia.

Entities:  

Keywords:  Central nervous system; Glioblastoma; Microglia; Therapy

Mesh:

Substances:

Year:  2016        PMID: 27714693     DOI: 10.1007/978-3-319-40764-7_12

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  8 in total

Review 1.  Vaccination in the immunotherapy of glioblastoma.

Authors:  Ziren Kong; Yu Wang; Wenbin Ma
Journal:  Hum Vaccin Immunother       Date:  2017-12-11       Impact factor: 3.452

2.  GBM-Derived Wnt3a Induces M2-Like Phenotype in Microglial Cells Through Wnt/β-Catenin Signaling.

Authors:  Diana Matias; Luiz Gustavo Dubois; Bruno Pontes; Luciane Rosário; Valeria Pereira Ferrer; Joana Balça-Silva; Anna Carolina Carvalho Fonseca; Lucy Wanjiku Macharia; Luciana Romão; Tania Cristina Leite de Sampaio E Spohr; Leila Chimelli; Paulo Niemeyer Filho; Maria Celeste Lopes; José Garcia Abreu; Flavia Regina Souza Lima; Vivaldo Moura-Neto
Journal:  Mol Neurobiol       Date:  2018-06-14       Impact factor: 5.590

Review 3.  Microglia/Astrocytes-Glioblastoma Crosstalk: Crucial Molecular Mechanisms and Microenvironmental Factors.

Authors:  Diana Matias; Joana Balça-Silva; Grazielle C da Graça; Caroline M Wanjiru; Lucy W Macharia; Carla Pires Nascimento; Natalia R Roque; Juliana M Coelho-Aguiar; Cláudia M Pereira; Marcos F Dos Santos; Luciana S Pessoa; Flavia R S Lima; Alberto Schanaider; Valéria P Ferrer; Vivaldo Moura-Neto
Journal:  Front Cell Neurosci       Date:  2018-08-03       Impact factor: 5.505

Review 4.  Cell-based immunotherapy of glioblastoma multiforme.

Authors:  Igor Bryukhovetskiy
Journal:  Oncol Lett       Date:  2022-02-23       Impact factor: 2.967

5.  AEG-1 silencing attenuates M2-polarization of glioma-associated microglia/macrophages and sensitizes glioma cells to temozolomide.

Authors:  Jing Li; Yuchen Sun; Xuanzi Sun; Xu Zhao; Yuan Ma; Yuzhu Wang; Xiaozhi Zhang
Journal:  Sci Rep       Date:  2021-08-30       Impact factor: 4.379

6.  Breast cancer metastasis to brain results in recruitment and activation of microglia through annexin-A1/formyl peptide receptor signaling.

Authors:  Sok Lin Foo; Karishma Sachaphibulkij; Corinne L Y Lee; Gracemary L R Yap; Jianzhou Cui; Thiruma Arumugam; Lina H K Lim
Journal:  Breast Cancer Res       Date:  2022-04-05       Impact factor: 6.466

7.  Identification of core genes as potential biomarkers for predicting progression and prognosis in glioblastoma.

Authors:  Jianping Zeng; Shushan Hua; Jing Liu; Rajneesh Mungur; Yongsheng He; Jiugeng Feng
Journal:  Front Genet       Date:  2022-09-27       Impact factor: 4.772

Review 8.  Adenosinergic Signaling as a Key Modulator of the Glioma Microenvironment and Reactive Astrocytes.

Authors:  Gabriela N Debom; Dominique S Rubenich; Elizandra Braganhol
Journal:  Front Neurosci       Date:  2022-01-05       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.